Señales en vivo de HOWL | Maximiza tus Ganancias con Getagraph.com

COMPRAR 114826 min ago

@ $6.85

Emitido: 9 feb 2024 @ 10:56

Retorno: -1.46%

Señal anterior: feb 8 - 11:03

Señal anterior: Vender

Retorno: 3.95 %

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer...

Stats
Volumen de hoy	82 150.00
Volumen promedio	227 943
Capitalización de mercado	288.48M
EPS	$0 ( 2024-03-28 )
Próxima fecha de ganancias	( $-0.350 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.43
ATR14	$0.0190 (0.28%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-04	Atkins Michael B.	Buy	35 000	Stock Option (right to buy)
2024-01-04	Atkins Michael B.	Sell	0	Common Stock
2024-01-02	Trost Timothy W.	Buy	150 000	Stock Option (right to buy)
2024-01-02	Lubman Ellen	Buy	131 900	Stock Option (right to buy)
2024-01-02	Isaacs Randi	Buy	200 000	Stock Option (right to buy)

INSIDER POWER
99.27
Last 97 transactions
Buy: 45 258 272 \| Sell: 143 550 934

Volumen Correlación

Largo: 0.24 (neutral)

Corto: -0.36 (neutral)

Signal:(59.175) Neutral

Werewolf Therapeutics, Correlación

10 Correlaciones Más Positivas
RMRM	0.939
APOP	0.918
FEYE	0.897
SVOK	0.88
TLGT	0.879
SVAC	0.874
GAINL	0.874
PAIC	0.861
SYBX	0.854
TDAC	0.851

10 Correlaciones Más Negativas
MMAC	-0.959
AMRB	-0.922
BOCH	-0.893
NETE	-0.888
RGP	-0.851
SBBP	-0.823
SHSP	-0.809

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Werewolf Therapeutics, Correlación - Moneda/Commodity

0.85
( strong )

0.86
( strong )

0.00
( neutral )

0.88
( strong )

0.49
( neutral )

-0.81
( strong negative )

Werewolf Therapeutics, Finanzas

Annual	2023
Ingresos:	$19.94M
Beneficio Bruto:	$18.18M (91.15 %)
EPS:	$-1.050

FY	2023
Ingresos:	$19.94M
Beneficio Bruto:	$18.18M (91.15 %)
EPS:	$-1.050

FY	2022
Ingresos:	$16.40M
Beneficio Bruto:	$13.89M (84.70 %)
EPS:	$-1.790

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-5.57

Financial Reports:

No articles found.

Werewolf Therapeutics,

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.